Population-level distribution and putative immunogenicity of cancer neoepitopes
Abstract Background Tumor neoantigens are drivers of cancer immunotherapy response; however, current prediction tools produce many candidates requiring further prioritization. Additional filtration criteria and population-level understanding may assist with prioritization. Herein, we show neoepitope...
Main Authors: | Mary A. Wood, Mayur Paralkar, Mihir P. Paralkar, Austin Nguyen, Adam J. Struck, Kyle Ellrott, Adam Margolin, Abhinav Nellore, Reid F. Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4325-6 |
Similar Items
-
An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2017-11-01) -
Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2018-05-01) -
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
by: Mary A. Wood, et al.
Published: (2020-03-01) -
Predicting T cell recognition of MHC class I restricted neoepitopes
by: Zeynep Koşaloğlu-Yalçın, et al.
Published: (2018-11-01) -
NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy
by: Jiaqi Xia, et al.
Published: (2021-04-01)